Novartis Chief Jimenez: "I knew exactly what I was getting into." This story ran in the February 27, 2012, edition of Forbes under the headline “Anticipation.” When you ask around the drug industry who the best leader of the last two decades was, Daniel

2/3/2012 8:13:34 AM Shareholder group Ethos called for Novartis investors to vote against re-electing board members who were among those deciding on the pay awarded to the Swiss drugmaker's chairman, Daniel Vasella. The call is part of an attack on Vasel

(Reuters) Shareholder group Ethos called for Novartis investors to vote against re-electing board members who were among those deciding on the pay awarded to the Swiss drugmaker's chairman, Daniel Vasella. The call is part of an attack on Vasella for "ea

* Ethos urges investors to vote out Novartis board members * Chairman's pay rose while net profit dropped * Ethos renews calls for UBS investment bank head to quit (Adds Novartis comment) ZURICH, Feb 2 (Reuters) - Shareholder group Ethos called for Novar

Daniel Vasella (photo) is wearing a bulls-eye again. The Novartis ($NVS) chairman is drawing fire for collecting a multimillion-dollar compensation package, just a few months after activists literally showed up on his doorstep to protest company layoffs.

ZURICH Feb 2 (Reuters) - Shareholder group Ethos said Novartis investors should vote against re-electing board members in charge of allotting bonus pay to the Swiss drugmaker's chairman, Daniel Vasella. The call is part of an attack on Vasella for "earni